Clinical Trials Directory

Trials / Recruiting

RecruitingNCT00177268

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

Peripheral Blood, Urine and Skin Sample Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
University of Pittsburgh · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.

Detailed description

The purpose of this study is to provide a central mechanism for monitoring access to peripheral blood, urine, and skin specimens obtained from CTCL, eczema, and atopic dermatitis patients to monitor: * immunologic assays/flow cytometry * tumor progression/regression * genomic studies * proteomic studies * others germane to the advancement of CTCL treatment

Conditions

Interventions

TypeNameDescription
OTHERBlood draw, skin biopsy or urine collectionUp to 9 blood draws/year of 60 ml of whole blood. One 6 mm punch biopsy may be obtained up to 4 times per year.

Timeline

Start date
2004-10-01
Primary completion
2030-01-01
Completion
2032-01-01
First posted
2005-09-15
Last updated
2025-12-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00177268. Inclusion in this directory is not an endorsement.